Results 101 to 110 of about 39,822 (286)

Pre‐anaesthetic risk assessment and management of dogs with myxomatous mitral valve disease: a spectrum of care narrative review

open access: yesJournal of Small Animal Practice, EarlyView.
Myxomatous mitral valve disease, an acquired valvular degeneration, is the most common cardiac disorder in dogs, affecting approximately 10% of dogs in primary care veterinary practice. Dogs with myxomatous mitral valve disease frequently require anaesthesia for routine procedures.
I. Levinzon   +3 more
wiley   +1 more source

Elevated antistreptolysin O titer is closely related to cardiac mitral insufficiency in untreated patients with Takayasu arteritis

open access: yesBMC Cardiovascular Disorders, 2020
Background The etiology of Takayasu arteritis (TA) is unknown; however, a possible relationship between streptococcal infection and TA has been proposed.
Lili Pan   +7 more
doaj   +1 more source

A new surgical approach for treating dilated cardiomyopathy with mitral regurgitation [PDF]

open access: yes, 2000
OBJECTIVE: To evaluate the early outcome of mitral valve prostheses implantation and left ventricular remodeling in 23 patients with end-stage cardiomyopathy and secondary mitral regurgitation (NYHA class III and IV).
Branco, João Nelson Rodrigues   +3 more
core   +1 more source

Population Pharmacokinetics of Sildenafil in Dogs With Naturally Occurring Pulmonary Hypertension

open access: yesJournal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT The pharmacokinetics of sildenafil are ill‐defined in dogs with naturally occurring pulmonary hypertension (PH). Because the plasma concentrations of sildenafil have not been reported for dogs with this disease, this study aimed to describe the population pharmacokinetics of sildenafil in a sample of dogs with PH. Twenty client‐owned dogs with
Mariko Yata   +3 more
wiley   +1 more source

Severe Concomitant Injury Complicated by Heart Valvular Apparatus Damage

open access: yesОбщая реаниматология, 2012
The paper describes a rare case of successful surgical treatment for mitral insufficiency due to heart valvular apparatus damage in the acute period of severe concomitant injury. Prosthetic mitral valve replacement was done on day 3 after injury.
V. N Yakovlev   +11 more
doaj   +1 more source

Maternal Cardiovascular Impairment in Pregnancies Complicated by Severe Fetal Growth Restriction [PDF]

open access: yes, 2012
—Fetal growth restriction and preeclampsia are both conditions of placental etiology and associated to increased risk for the long-term development of cardiovascular disease in the mother. At presentation, preeclampsia is associated with maternal global
Liberati, M   +3 more
core   +1 more source

Segmental Snare Traction Technique for Helix‐Fixed Leadless Pacemaker Implantation Across a Repaired Tricuspid Annulus

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Helix‐fixed leadless pacemaker delivery can be challenging after tricuspid annuloplasty with a rigid ring. An 80‐year‐old woman with prior mitral valve repair, tricuspid annuloplasty (26‐mm MC ring), and Maze III surgery presented with syncope due to atrial fibrillation with a slow ventricular response. Standard maneuvers failed to advance the
Yuya Nakamura   +5 more
wiley   +1 more source

Assessment and management of a 1.77‐cm2 mitral leaflet perforation as a subclinical cause of mitral regurgitation

open access: yesClinical Case Reports, 2018
Key Clinical Message Anterior mitral valve perforations are commonly due to underlying infective endocarditis, which can lead to significant mitral valve insufficiency.
Paras Patel   +4 more
doaj   +1 more source

Minimally invasive mitral valve repair: a new surgical option for mitral insufficiency [PDF]

open access: yes, 2010
Minimally invasive mitral valve repair (MIMVR) is a relatively new alternative to median sternotomy for valvular heart surgery, and has become increasingly appealing due to its improved cosmetic results and more rapid recovery time.
Raith, E.
core  

Treatment of dogs with compensated myxomatous mitral valve disease with spironolactone-a pilot study [PDF]

open access: yes, 2017
Spironolactone improves outcome in dogs with advanced myxomatous mitral valve disease (MMVD). Its efficacy in preclinical MMVD is unknown. The hypothesis was the administration of spironolactone to dogs with compensated MMVD demonstrating risk factors ...
Boswood, A   +4 more
core   +3 more sources

Home - About - Disclaimer - Privacy